| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
0.83 0.03 (0.04%) |
06-17 16:00 |
|
Open: |
0.8 |
Pre close: |
0.8 |
Target:
|
1.21 
|
|
High: |
0.8789 |
Low: |
0.7822 |
Resistance:
|
1.04
1.21
|
|
Volume: |
653,780 |
Market Cap: |
119M |
Support:
|
0.77
0.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.81
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
0.91 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.06 |
Stochastic Oscillator |
%K(14,3):
|
53.26 |
|
MA(250): |
0.80 |
%D(3): |
51.65 |
|
Average Volume(K) |
3-Month: |
87428
|
52-Week |
High:
|
1.50 |
|
10-Days: |
77594 |
Low: |
0.32 |
|
RSI |
RSI(14):
|
35.95 |
Change(%): |
49.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-83.9 |
Shares Out. (M) |
142.99 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-49.3 |
Shares Float (M) |
133.63 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
26.00 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5331 |
|
Book Value (p.s.) |
3.860 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.54 |
P/S |
0.00 |
|
Operating Margin |
-16288.19 |
Levered Free Cash Flow
(M) |
-4.56 |
P/CF |
-11.14 |
|
|
|
|
|
|
